Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Sitosterolemia is an autosomal recessive disorder characterized by increased plant sterol levels, xanthomas, and accelerated atherosclerosis. Although it was originally reported in patients with normolipemic xanthomas, severe hypercholesterolemia have been reported in patients with sitosterolemia, especially in children. Sitosterolemia is caused by increased intestinal absorption and decreased biliary excretion of sterols resulting from biallelic mutations in either ABCG5 or ABCG8, which encode the sterol efflux transporter ABCG5 and ABCG8. Patients with sitosterolemia show extreme phenotypic heterogeneity, ranging from almost asymptomatic individuals to those with severe hypercholesterolemia leading to accelerated atherosclerosis and premature cardiac death. Hematologic manifestations include hemolytic anemia with stomatocytosis, macrothrombocytopenia, splenomegaly, and abnormal bleeding. The mainstay of therapy includes dietary restriction of both cholesterol and plant sterols and the sterol absorption inhibitor, ezetimibe. Foods rich in plant sterols include vegetable oils, wheat germs, nuts, seeds, avocado, shortening, margarine and chocolate. Hypercholesterolemia in patients with sitosterolemia is dramatically responsive to low cholesterol diet and bile acid sequestrants. Plant sterol assay should be performed in patients with normocholesterolemic xanthomas, hypercholesterolemia with unexpectedly good response to dietary modifications or to cholesterol absorption inhibitors, or hypercholesterolemia with poor response to statins, or those with unexplained hemolytic anemia and macrothrombocytopenia. Because prognosis can be improved by proper management, it is important to find these patients out and diagnose correctly. This review article aimed to summarize recent publications on sitosterolemia, and to suggest clinical indications for plant sterol assay.
Abstract
Sitosterolemia is an autosomal recessive disorder characterized by increased plant sterol levels, xanthomas, and accelerated atherosclerosis. Although it was originally reported in patients with normolipemic xanthomas, severe hypercholesterolemia have been reported in patients with sitosterolemia, especially in children. Sitosterolemia is caused by increased intestinal absorption and decreased biliary excretion of sterols resulting from biallelic mutations in either ABCG5 or ABCG8, which encode the sterol efflux transporter ABCG5 and ABCG8. Patients with sitosterolemia show extreme phenotypic heterogeneity, ranging from almost asymptomatic individuals to those with severe hypercholesterolemia leading to accelerated atherosclerosis and premature cardiac death. Hematologic manifestations include hemolytic anemia with stomatocytosis, macrothrombocytopenia, splenomegaly, and abnormal bleeding. The mainstay of therapy includes dietary restriction of both cholesterol and plant sterols and the sterol absorption inhibitor, ezetimibe. Foods rich in plant sterols include vegetable oils, wheat germs, nuts, seeds, avocado, shortening, margarine and chocolate. Hypercholesterolemia in patients with sitosterolemia is dramatically responsive to low cholesterol diet and bile acid sequestrants. Plant sterol assay should be performed in patients with normocholesterolemic xanthomas, hypercholesterolemia with unexpectedly good response to dietary modifications or to cholesterol absorption inhibitors, or hypercholesterolemia with poor response to statins, or those with unexplained hemolytic anemia and macrothrombocytopenia. Because prognosis can be improved by proper management, it is important to find these patients out and diagnose correctly. This review article aimed to summarize recent publications on sitosterolemia, and to suggest clinical indications for plant sterol assay.
참고문헌 (66)
- Salen G, "Sitosterolemia", J Lipid Res, 33, pp.945~955 (1992)
- "Sitosterolemia. GeneReviews" (2016)[URL]
- Berge KE, "Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters", Science, 290, pp.1771~1775 (2000)
- Lu K, "Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively", Am J Hum Genet, 69, pp.278~290 (2001)
- Patel SB, "Recent advances in understanding the STSL locus and ABCG5", ABCG8 biology, 2014, pp.25, 169~175
- Othman R A, "Non-cholesterol sterols and cholesterol metabolism in sitosterolemia", Atherosclerosis, 231, pp.29~29 (2013)
- R ees D C, "Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis", macrothrombocytopenia) is the haematological presentation of phytosterolaemia, 2005, pp.130, 297~309
- Escola-Gil JC, "Sitosterolemia: diagnosis, investigation, and management", Curr Atheroscler Rep, 16, pp.424~ (2014)
- Wilund KR, "No association between plasma levels of plant sterols and atherosclerosis in mice and men", Arterioscler Thromb Vasc Biol, 24, pp.2326~2332 (2004)
- Miettinen TA, "Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis", Eur J Clin Invest, 10, pp.27~35 (1980)
- Izar MC, "Phytosterols and phytosterolemia: gene-diet interactions", Genes Nutr, 6, pp.17~26 (2011)
- Solca C, "Dietary xenosterols lead to infertility and loss of abdominal adipose tissue in sterolindeficient mice", J Lipid Res, 54, pp.397~409 (2013)
- McDaniel AL, "Phytosterol feeding causes toxicity in ABCG5", G8 knockout mice, 2013, pp.182, 1131~1138
- Calpe-Berdiel L, "Increased plasma levels of plant sterols and atherosclerosis: a controversial issue", Curr Atheroscler Rep, 11, pp.391~398 (2009)
- Doggrell SA, "Lowering LDL cholesterol with margarine containing plant stanol", sterol esters: is it still relevant in 2011?, 2011, pp.19, 37~46
- Assmann G, "Plasma sitosterol elevations are associated with an increased incidence of coronary events in men:results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study", Nutr Metab Cardiovasc Dis, 16, pp.13~21 (2006)
- Helske S, "Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves", J Lipid Res, 49, pp.1511~1518 (2008)
- Weingärtner O, "The atherogenicity of plant sterols: the evidence from genetics to clinical trials", J AOAC Int, 98, pp.742~749 (2015)
- Yu L, "The structure and function of Niemann-Pick C1-like 1 protein", Curr Opin Lipidol, 19, pp.263~269 (2008)
- Kwon HJ, "The structure of the NPC1L1 N-terminal domain in a closed conformation", PLoS One, 6, pp.e18722~ (2011)
- Lee RG, "Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates", J Lipid Res, 41, pp.1991~2001 (2000)
- Temel RE, "Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol", J Biol Chem, 278, pp.47594~47601 (2003)
- Salen G, "Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis", J Lipid Res, 26, pp.1126~1133 (1985)
- Miettinen TA, "Liver transplantation in a patient with sitosterolemia and cirrhosis", Gastroenterology, 130, pp.542~547 (2006)
- Wang J, "Relative roles of ABCG5", ABCG8 in liver and intestine, 2015, pp.56, 319~330
- Myrie SB, "Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals", Am J Clin Nutr, 95, pp.837~844 (2012)
- Bhattacharyya AK, "Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters", J Clin Invest, 53, pp.1033~1043 (1974)
- Wang J, "Phenotypic heterogeneity of sitosterolemia", J Lipid Res, 45, pp.2361~2367 (2004)
- Hu M, "Potential effects of NPC1L1 polymorphisms in protecting against clinical disease in a chinese family with sitosterolaemia", J Atheroscler Thromb, 21, pp.989~995 (2014)
- Hansel B, "Premature atherosclerosis is not systematic in phytosterolemic patients: severe hypercholesterolemia as a confounding factor in five subjects", Atherosclerosis, 234, pp.162~168 (2014)
- Mannucci L, "Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene", Eur J Clin Invest, 37, pp.997~1000 (2007)
- Niu DM, "Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and children", J Inherit Metab Dis, 33, pp.437~443 (2010)
- Rios J, "Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia", Hum Mol Genet, 19, pp.4313~4318 (2010)
- Drozdowski LA, "Ontogeny, growth and development of the small intestine: Understanding pediatric gastroenterology", World J Gastroenterol, 16, pp.787~799 (2010)
- Park JH, "Sitosterolemia presenting with severe hypercholesterolemia and intertriginous xanthomas in a breastfed infant:case report and brief review", J Clin Endocrinol Metab, 99, pp.1512~1518 (2014)
- Kamelska AM, "Variation of the cholesterol content in breast milk during 10 days collection at early stages of lactation", Acta Biochim Pol, 59, pp.243~247 (2012)
- Sethuraman G, "Familial homozygous hypercholesterolemia: report of two patients and review of the literature", Pediatr Dermatol, 24, pp.230~234 (2007)
- Canizales-Quinteros S, "A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia", Hum Genet, 116, pp.114~120 (2005)
- Manchanda Y, "Intertriginous xanthomas: a marker of homozygous type IIa hyperlipoproteinemia", Int J Dermatol, 43, pp.676~677 (2004)
- Zak A, "Xanthomas: clinical and pathophysiological relations", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 158, pp.181~188 (2014)
- Oosterveer DM, "Sijbrands EJ. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis", Atherosclerosis, 207, pp.311~317 (2009)
- Menotti A, "Cardiovascular risk factors predict survival in middle-aged men during 50 years", Eur J Intern Med, 24, pp.67~74 (2013)
- Belamarich PF, "Response to diet and cholestyramine in a patient with sitosterolemia", Pediatrics, 86, pp.977~981 (1990)
- Parsons HG, "A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia", Clin Invest Med, 18, pp.389~400 (1995)
- Salen G, "Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis", Gastroenterology, 130, pp.1853~1857 (2006)
- Cheng WF, "Sitosterolaemia and xanthomatosis in a child", Hong Kong Med J, 9, pp.206~209 (2003)
- Mymin D, "Image in cardiovascular medicine. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8", Circulation, 107, pp.791~ (2003)
- Kwiterovich PO Jr, "Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia", Lancet, 1, pp.466~469 (1981)
- Falk E, "Coronary plaque disruption", Circulation, 92, pp.657~671 (1995)
- Bao L, "Sitosterolcontaining lipoproteins trigger free sterol-induced caspaseindependent death in ACAT-competent macrophages", J Biol Chem, 281, pp.33635~33649 (2006)
- Kolovou G, "Coronary bypass grafts in a young girl with sitosterolemia", Eur Heart J, 17, pp.965~966 (1996)
- Su Y, "Clinical and molecular genetic analysis of a family with sitosterolemia and co-existing erythrocyte and platelet abnormalities", Haematologica, 91, pp.1392~1395 (2006)
- Wang Z, "Specific macrothrombocytopenia", hemolytic anemia associated with sitosterolemia, 2014, pp.89, 320~324
- Kaya Z, "A novel mutation of ABCG5 gene in a Turkish boy with phytosterolemia presenting with macrotrombocytopenia and stomatocytosis", Pediatr Blood Cancer, 61, pp.1457~1459 (2014)
- Kanaji T, "Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia", Blood, 122, pp.2732~2742 (2013)
- Honda A, "Down-regulation of cholesterol biosynthesis in sitosterolemia: diminished activities of acetoacetyl-CoA thiolase, 3-hydroxy-3-methylglutaryl-CoA synthase, reductase, squalene synthase, and 7-dehydrocholesterol delta7reductase in liver and mononuclear leukocytes", J Lipid Res, 39, pp.44~50 (1998)
- Plat J, "Plant sterols and stanols:effects on mixed micellar composition and LXR (target gene) activation", J Lipid Res, 46, pp.2468~2476 (2005)
- Yang C, "Disruption of cholesterol homeostasis by plant sterols", J Clin Invest, 114, pp.813~822 (2004)
- Nguyen L, "Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin", Arteriosclerosis, 10, pp.28997~ (1990)
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, "Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report", Pediatrics, 128(Suppl 5), pp.S213~S256 (2011)
- Lutjohann D, "Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study", Int J Clin Pract, 62, pp.1499~1510 (2008)
- Gregg RE, "Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis", J Clin Invest, 77, pp.1864~1872 (1986)
- Tsubakio-Yamamoto K, "Current therapy for patients with sitosterolemia: effect of ezetimibe on plant sterol metabolism", J Atheroscler Thromb, 17, pp.891~900 (2010)
- Salen G, "Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia", Circulation, 109, pp.966~971 (2004)
- Othman RA, "Ezetimibe reduces plant sterol accumulation and favorably increases platelet count in sitosterolemia", J Pediatr, 166, pp.125~131 (2015)
- Kavey RE, "Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics", Circulation, 114, pp.2710~2738 (2006)